Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. - Wikidata - awgldk - TriplyDB

Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS.

Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS.

http://www.wikidata.org/entity/Q33817911

about

Prolonged Glucocorticoid Treatment in ARDS: Impact on Intensive Care Unit-Acquired Weakness Argument against the Routine Use of Steroids for Pediatric Acute Respiratory Distress Syndrome ICU-acquired weakness: what is preventing its rehabilitation in critically ill patients?Toxic myopathies Elderly persons with ICU-acquired weakness: the potential role for β-hydroxy-β-methylbutyrate (HMB) supplementation?Year in review in Intensive Care Medicine 2009: II. Neurology, cardiovascular, experimental, pharmacology and sedation, communication and teaching.Risk factors for physical impairment after acute lung injury in a national, multicenter study.Electrophysiology of neuromuscular disorders in critical illness.Symptoms of depression in survivors of severe sepsis: a prospective cohort study of older Americans.Steroids for acute respiratory distress syndrome?An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults.Get out of bed: immobility in the neurologic ICU.Physical therapy management and patient outcomes following ICU-acquired weakness: a case series.Acute respiratory distress syndrome: pathophysiology and therapeutic options The challenge of designing a post-critical illness rehabilitation intervention.Assessment and predictors of physical functioning post-hospital discharge in survivors of critical illness.Physical complications in acute lung injury survivors: a two-year longitudinal prospective study.Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome.Outcome of ICU survivors: a comprehensive review. The role of patient-reported outcome studies.Persistent systemic inflammation in chronic critical illness.Acute lung injury and acute respiratory distress syndrome requiring tracheal intubation and mechanical ventilation in the intensive care unit: impact on managing uncertainty for patient-centered communication.Sepsis: a review for the neurohospitalist.How outcomes are defined in clinical trials of mechanically ventilated adults and children.Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.Nutritional care after critical illness: a qualitative study of patients' experiences.[Critical illness polyneuropathy and myopathy as neurological complications of sepsis].Physical activity, muscle strength, and exercise capacity 3 months after severe sepsis and septic shock.Neuromuscular involvement in vegetative and minimally conscious states following acute brain injury.Prediction and Outcome of Intensive Care Unit-Acquired Paresis.Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: yes.Impact of early mobilization on glycemic control and ICU-acquired weakness in critically ill patients who are mechanically ventilated.ICU-Acquired Weakness.8th International conference on management and rehabilitation of chronic respiratory failure: the long summaries – part 2.Sepsis-induzierte CIP und CIM Continuation or Discontinuation of Statin Therapy Did Not Influence Patient Outcomes after the Development of Acute Respiratory Distress Syndrome

P2860

Q26741099-5F44F370-00B0-4068-A7D7-E22B955CA81A Q26741709-46C6B6E5-A913-4B07-947F-84AD52176E5A Q26861446-F8636892-647F-4935-89E1-89CD0AB7C9EA Q27007256-30BD12C3-350E-45D7-835F-C0FC64A02F1F Q28299355-88ED1F5F-7A64-4460-B85D-90AD4589C071 Q33646147-E6ED1FD9-8B9E-45E4-AE37-92595D63C1E2 Q33772265-49A22522-932C-4684-BA2B-8BD3456DDB82 Q34326509-0BF5D907-D875-498F-B3CB-9401B427B88F Q34337900-48E38C97-D13B-43A2-BEDC-D0E48EDADBEA Q34451061-C27C649A-6E9A-4DEB-9FF7-153C9E0B8FB9 Q34453145-2ABD67F9-BC8D-4DD1-8193-0A27C4A83FAB Q35180186-24D45222-FCE3-401C-B4EE-30E76E211244 Q35226431-87D81694-16E7-4030-B622-6C77EE635747 Q35757010-94C5E182-37A3-4346-9CBA-C3C15B1ABC23 Q35908034-A027B3B4-73D1-4E8F-8C3D-614D54CB4588 Q37266138-994AEF4F-0D2C-41D5-9B8F-008C51BD65BF Q37646839-DC5244C2-71F8-4AEA-826F-D6295083A428 Q37734444-E39BCEF8-1A6D-4FA2-8586-B09BFC52708A Q37999431-920AA6FC-79E1-4263-8F74-44FEA444A00D Q38015927-D1446AB2-878C-440E-9B16-632B875CB09B Q38046829-94821914-CAB2-4FE1-85A9-DED0B3EDF65B Q38132155-60AF6FDC-C48B-43E3-8802-21EDCDC3F3A4 Q38186788-A52AA541-9E5A-491E-8EE2-F1D9E67B9A2D Q38225008-A3FCF7D2-C481-4287-A2B4-87170BD191DD Q39072190-A9419C1B-0DEF-414D-A432-2CE9744E3FB6 Q40806336-0BD48B8A-0C81-4218-A143-CD72C770CA98 Q41141301-B6CCF37A-2511-4BC1-9C7E-0D7B41E42D74 Q45777397-2C92E9AF-01F2-43EC-8978-BAE66CABF5DA Q46896951-A996CC90-16FC-4656-A7C0-B38C62542A95 Q47590034-DC8D6E3D-191C-4D6C-8DF8-93CFEAD08DE7 Q50355355-E2B408D1-654E-49C8-8DA4-EE24574CBEA5 Q50862714-A9D84737-ADEB-415C-ABA6-56FEC6F43A45 Q54900797-D293E185-357B-4B04-8F5D-EB9E4562E3C6 Q57727086-29991853-B7A8-4A39-A968-AAA21F4A1D54 Q58995173-10F3A99D-5C8E-4BB6-889F-C921057AA2D1

P2860

Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS.

http://www.wikidata.org/entity/Q33817911

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Intensive care unit-acquired n ...... survivors of persistent ARDS.

@ast

Intensive care unit-acquired n ...... survivors of persistent ARDS.

@en

type

label

Intensive care unit-acquired n ...... survivors of persistent ARDS.

@ast

Intensive care unit-acquired n ...... survivors of persistent ARDS.

@en

prefLabel

Intensive care unit-acquired n ...... survivors of persistent ARDS.

@ast

Intensive care unit-acquired n ...... survivors of persistent ARDS.

@en

P1433

Q33817911-9C83F8C8-0A73-4AE9-94CF-AC3450BA7797

P1476

Q33817911-9AF82D8F-D487-4514-AB22-82DE9D312969

P2093

Q33817911-1F76E3BC-7DE1-4204-A1FE-E34330A21621

Q33817911-45C98143-AE7B-4DCA-8271-F85CD1572826

Q33817911-9B0C0142-96F1-4DEA-AD07-E6532218E1ED

Q33817911-AC1719D7-2785-4F6F-A755-C95715307657

Q33817911-C95E4BC6-F807-44C3-90E3-66C14A191741

P2860

Q33817911-0AC6AD0F-1FC5-4E65-A75D-99B8E351F230

Q33817911-15979BDC-48C8-4E53-8177-CD12D068448D

Q33817911-177DAAFA-B2B5-428A-8571-D0AF9F58456A

Q33817911-575EF25B-26EE-4681-98E0-984134C29B8D

Q33817911-57BEFD6D-A060-4E69-976C-00C17D0DBE8F

Q33817911-65CB16B6-6240-4947-8B26-5930CEEE51F7

Q33817911-697F160F-4EEC-482D-AC69-CC8F8ECBA07D

Q33817911-6AE328DF-F64F-4021-A94F-FD42BCB22805

Q33817911-7B55ABF3-B43F-44E9-85E2-55443B3321FB

Q33817911-7F769E1C-A8B8-405C-B8E9-98F7DD8E2A4E

P2888

Q33817911-54D74104-CE91-4EA5-BE40-1E22F611F0DC

P304

Q33817911-E36F58C4-3A2C-4524-AEB9-A57A4EDBD855

P31

Q33817911-55E17B7A-ACBB-4D65-9E95-9D4B0C06348C

P356

Q33817911-54D2CD53-88DD-4531-9164-5D0893FE1BDC

P433

Q33817911-83F36257-1DB7-4E72-A8F5-2CD56441AD3F

P478

Q33817911-6B4A54FA-1E12-4DF5-81C0-3F085BEF43B9

P577

Q33817911-2B651D90-06B5-4A44-BDDE-9B3242FDD84E

P5875

Q33817911-81E5794E-22A5-4C50-9214-3D85EC41C68A

P698

Q33817911-33A8A89A-3359-49C6-9CF2-2032C54F9790

P921

Q33817911-1065AA6A-D3AA-43B7-94B8-D5C9071B3C2C

Q33817911-BE1BD95D-15FF-4731-925A-410E0016CC41

P932

Q33817911-0404F724-83F3-4780-8CD5-F15210484B57

P356

S00134-008-1304-4

P1433

Intensive Care Medicine

P1476

Intensive care unit-acquired n ...... survivors of persistent ARDS.

@en

P2093

B Taylor Thompson

http://www.w3.org/2001/XMLSchema#string

Catherine L Hough

http://www.w3.org/2001/XMLSchema#string

Gordon D Rubenfeld

http://www.w3.org/2001/XMLSchema#string

Kenneth P Steinberg

http://www.w3.org/2001/XMLSchema#string

Leonard D Hudson

http://www.w3.org/2001/XMLSchema#string

P2860

Critical illness myopathy: what is happening?

Neuromuscular dysfunction acquired in critical illness: a systematic review.

Paresis acquired in the intensive care unit: a prospective multicenter study.

Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.

Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit.

Origin of ICU acquired paresis determined by direct muscle stimulation

Neuromuscular sequelae in survivors of acute lung injury.

Acute myopathy after liver transplantation.

Peripheral nerve function in sepsis and multiple organ failure.

Risk factors for the development of polyneuropathy and myopathy in critically ill patients.

P2888

s00134-008-1304-4

P304

63-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00134-008-1304-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23407818

http://www.w3.org/2001/XMLSchema#string

P698

18946661

http://www.w3.org/2001/XMLSchema#string

P921

acute respiratory distress syndrome

intensive care unit

P932

2861487

http://www.w3.org/2001/XMLSchema#string